Rodeck B, Becker A C, Gratz K F, Petersen C
Clinic of Pediatrics, Marienhospital Osnabrück, Osnabrück, Germany.
Eur J Pediatr Surg. 2007 Oct;17(5):308-12. doi: 10.1055/s-2007-965518.
Aim of the study was the evaluation of early predictive parameters of event-free survival (not listed for liver transplantation, not transplanted, no death) in children suffering from biliary atresia after hepatoportoenterostomy (Kasai procedure) in order to optimize pretransplant management.
Sixty-seven infants were treated with the Kasai operation at our institution over a 20-year period from 1978 until 1998. Median age at time of operation was 51 days after birth (range 19 - 180 days). Of these 67 infants, 24 children with complete datasets and an observation time of at least one year were evaluated retrospectively using a Cox regression model. The response variable was event-free survival after a median observation time of 4.9 years (1.11- 10.37 years). Six variables were entered as covariates: alanine aminotransferase (ALAT), cholinesterase activity, bilirubin, age at the time of Kasai operation and tracer excretion and uptake during hepatobiliary scintigraphy (HBSS). All variables were evaluated six weeks after operation. For subsequent cut-off determination, a receiver operating analysis (ROC analysis) was carried out.
Tracer excretion shown by HBSS showed the highest prognostic power to predict event-free survival after Kasai operation (log rank 18.68, p < 0.0001) followed by bilirubin and ALAT as further significant parameters in the first univariate step of the Cox regression model. In the subsequent multivariate step, the prognostic power of HBSS was improved only by bilirubin (log rank 24.6, p < 0.0001). The ROC analysis determined a cut-off for bilirubin concentrations of 57 micromol/l for event-free survival with a sensitivity of 80 % and a specificity of 78.6 %. The five-year event-free survival-rate was 100 % in the group with good tracer excretion and a bilirubin concentration of 57 micromol/l and 27 % for the other group (log rank test, p < 0. 0001).
Early predictors of success of the Kasai operation in children with biliary atresia are free tracer excretion as shown by HBSS and a serum bilirubin concentration < 57 micromol/l six weeks after the operation. Thus, children with bilirubin concentrations above this level should be carefully and frequently monitored with regard to a transplantation requirement in order to optimize pretransplant management.
本研究旨在评估接受肝门空肠吻合术(Kasai手术)的胆道闭锁患儿无事件生存(未列入肝移植、未接受移植、未死亡)的早期预测参数,以优化移植前管理。
1978年至1998年的20年间,我院对67例婴儿实施了Kasai手术。手术时的中位年龄为出生后51天(范围19 - 180天)。在这67例婴儿中,对24例拥有完整数据集且观察时间至少1年的患儿,采用Cox回归模型进行回顾性评估。应变量为中位观察时间4.9年(1.11 - 10.37年)后的无事件生存。六个变量作为协变量纳入:丙氨酸氨基转移酶(ALAT)、胆碱酯酶活性、胆红素、Kasai手术时的年龄以及肝胆闪烁显像(HBSS)期间的示踪剂排泄和摄取情况。所有变量均在术后六周进行评估。为确定后续的截断值,进行了受试者操作分析(ROC分析)。
HBSS显示的示踪剂排泄对预测Kasai手术后的无事件生存具有最高的预后价值(对数秩检验18.68,p < 0.0001),其次是胆红素和ALAT,它们是Cox回归模型单变量分析第一步中的其他显著参数。在随后的多变量分析步骤中,仅胆红素提高了HBSS的预后价值(对数秩检验24.6,p < 0.0001)。ROC分析确定无事件生存的胆红素浓度截断值为57微摩尔/升,敏感性为80%,特异性为78.6%。示踪剂排泄良好且胆红素浓度<57微摩尔/升的组,五年无事件生存率为100%,另一组为27%(对数秩检验,p < 0.0001)。
胆道闭锁患儿Kasai手术成功的早期预测指标是HBSS显示的示踪剂自由排泄以及术后六周血清胆红素浓度<57微摩尔/升。因此,对于胆红素浓度高于此水平的患儿,应密切且频繁监测其移植需求,以优化移植前管理。